Status:
COMPLETED
Evaluation of the Prevalence of Pelvic Static Disorders in Women With Localized Breast Cancer
Lead Sponsor:
Institut du Cancer de Montpellier - Val d'Aurelle
Conditions:
Breast Cancer
Eligibility:
FEMALE
50+ years
Brief Summary
In this study, investigator propose to assess the prevalence of pelvic static disorders in women undergoing adjuvant hormone therapy for localized breast cancer and to assess the overall quality of li...
Detailed Description
Breast cancer is the most common cancer in women. Its incidence increases with 58,459 new cases in France in 2018, however its mortality decreases with a survival rate of 87% at 5 years. Therapeutic ...
Eligibility Criteria
Inclusion
- Women with Age ≥ 50 years
- Menopaused
- Patient followed for carcinoma in situ or infiltrating the breast with or without hormone therapy
- Patient who was treated by surgery after June 2015, whether or not followed by radiotherapy or chemotherapy.
- Patient who agreed, after receiving information, to participate to the study.
Exclusion
- Metastatic breast cancer
- Patient with a history of pelvic static surgery
- Patient with a history of pelvic irradiation
- Patient unable or unwilling to complete the questionnaires
- Patient with a history of urinary incontinence treatment
- Patient not affiliated to the French social security system
- Subject under tutelage, curatorship or safeguard of justice,
- Patient in an emergency situation,
- Patient whose regular monitoring is impossible for psychological, family, social or geographical reasons,
- Pregnant and / or breastfeeding woman.
Key Trial Info
Start Date :
September 18 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 6 2021
Estimated Enrollment :
246 Patients enrolled
Trial Details
Trial ID
NCT04515888
Start Date
September 18 2020
End Date
July 6 2021
Last Update
November 4 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Icm Val D'Aurelle
Montpellier, Herault, France, 34298